A Prospective, Multicenter, Single-Arm Trial With the Lutonix Drug Coated Balloon for Treatment of Long Lesions in Femoropopliteal Arteries
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 04 May 2017
At a glance
- Drugs Paclitaxel (Primary)
- Indications Peripheral arterial disorders
- Focus Adverse reactions; Therapeutic Use
- 27 Apr 2017 Planned End Date changed from 1 Mar 2018 to 1 Jun 2018.
- 30 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 04 Sep 2015 New trial record